Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-04-27
1981-03-03
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 422 61, 424 12, 424 88, G01N 3348, G01T 100, C01G 700, B65D 700
Patent
active
042540950
ABSTRACT:
A kit and method for the radioimmunoassay (RIA) for erythropoietin. Also, a method for purifying erythropoietin and purified labelled erythropoietin-conjugate for use as a tracer in the RIA.
REFERENCES:
Rege et al., 11, Fed. Proc., 36:1287 (1977).
Fisher et al., Abstract for 3rd Int. Congress of Hematology, Munich, Germany, Aug. 2-8, 1970.
Bolton et al., Biochem. J., 133:529-539 (1973).
Bruno, In New Techniques in Tumor Location and Radioimmonoassay, Ed. Croll et al., J. Wiley and Sons, New York, 1974, pp. 9-15.
Fisher James W.
Rege Arvind B.
Nucker Christine M.
Padgett Benjamin R.
Research Corporation
Williams, Jr. Sidney B.
LandOfFree
Radioimmunoassay for erythropoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassay for erythropoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassay for erythropoietin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-79837